Skip to main content
Fig. 4 | Health and Quality of Life Outcomes

Fig. 4

From: Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study

Fig. 4

Change in PROMIS scores from baseline to month 12 visit. Participants were classified by proteinuria remission status at month 12. All participants were disease active at baseline. Remission was defied as normalization of urinary protein excretion and complete resolution of edema. Results are shown as mean change with 95% confidence intervals. Sample sizes: Remission = 49, Active = 41. Minimally Important Difference (MID)

Back to article page